Nav: Home

Calixarenes in lipase biocatalysis and cancer therapy

August 17, 2016

Calixarenes bear a fascinating class of macrocycles that have served broadly in molecular recognition and supramolecular chemistry. These, supramolecular structures have been utilized in several different directions ranging from catalysis to therapy. Their multifactorial significance originates from their structural plasticity and the fact that they can be easily derivatized and manipulated to adapt and complement a mosaic of different specifications and applications. This paper provides an overview of the utilization of calixarenes in biocatalysis and cancer therapy and diagnosis. Several different examples are presented on the capacity of calixarenes to enhance the stereo- and regio-selectivity as also the catalytic potency of lipases. This ability of calixarenes to amplify, upon hosting different enzymes their catalytic capacity, can be fruitfully explored to develop novel therapeutics. Calixarenes can also facilitate and decrease the time required for the synthesis of complex molecules. This potential is further advanced upon appropriate formulation with magnetic nanoparticles that can ease the regeneration and separation of the biocatalyst from the reaction mixture. Such developments are especially important in complex diseases such as cancer, where there is an immense need of novel therapeutics as also drug formulations. Due to the ability of calixarenes to be tailored with different functional groups they can accommodate different cytotoxic agents and thus can serve as drug delivery vehicles. Through such formulations the pharmacokinetic profile of the original drug is refined. Calixarenes have also obliged as drug delivery machineries that are responsive to the tumor microenvironment and a selective release of the drug to cancer cells has been achieved. Besides cancer treatment calixarenes have also served as promising diagnostic biomarkers for early stage cancer. The reported examples highlighted in this work illuminate the applicability of calixarenes to advance the field of biocatalysis and cancer therapeutics and diagnostics. This intriguing scaffold and its associated plasticity should be further explored to model the construction of multifunctional and smart molecular machineries that could assist the synthesis of novel complex scaffolds and theranostics.
-end-
Reference: Karakurt, S.; et al. (2016). Calixarenes in Lipase Biocatalysis and Cancer Therapy, Curr. Org. Chem., DOI: 10.2174/1385272820666151211192249

For more information about the article, please visit http://benthamscience.com/journals/current-organic-chemistry/article/137782/

Bentham Science Publishers

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.